• / Free eNewsletters & Magazine
  • / My Account
Home>Global Pharmaceutical Traceability Market - Growth Opportunity Assessment | Technavio

Global Pharmaceutical Traceability Market - Growth Opportunity Assessment | Technavio

Global Pharmaceutical Traceability Market - Growth Opportunity Assessment | Technavio

09/28/2017

Global Pharmaceutical Traceability Market - Growth Opportunity Assessment | Technavio

The global pharmaceutical traceability market is expected to grow at a CAGR of more than 19% during the forecast period, according to Technavio’s latest report.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170928005802/en/

Technavio has published a new report on the global pharmaceutical traceability market from 2017-2021 ...

Technavio has published a new report on the global pharmaceutical traceability market from 2017-2021. (Graphic: Business Wire)

In this report, Technavio covers the market outlook and growth prospects of the global pharmaceutical traceability market for 2017-2021. The market is segmented by type of technology (barcode, RFID, GPS, and others) and geography (the Americas, APAC, and EMEA).

The demand for pharmaceutical traceability has grown over the years because of the rising concerns for global drug counterfeiting. The strict regulations from governments and vendors adopting new technologies have helped in improving the traceability of systems through track and trace and serialization. For example, companies like AlpVision have introduced a feature called Cryptoglyph, which uses a digital invisible marking on the labels. This marking is a digital image file that contains encrypted information that can be verified using a scanner and smartphone having the AlpVision application.

Technavio’s transportation and logistics research analysts categorize the global pharmaceutical traceability market into the following segments by regions:

  • Americas
  • APAC
  • EMEA

Looking for more information on this market? Request a free sample report

©2017 Morningstar Advisor. All right reserved.